Funded Local Who is raising money in your own backyard?

Kelowna, BC, June 10, 2009 – QHR Technologies Inc. (“QHR” or the “Company”) (TSXVenture:QHR) announced that the company has arranged a non-brokered private placement to raise up to $1,000,000. The private placement consists of up to 2,000,000 units at a price of $0.50 per unit. Each unit consists of one common share and one non-transferable share purchase warrant. One warrant will entitle the holder to purchase one additional common share of the Company exercisable at a price of $0.60 within one year of closing or $0.70 within two years of closing.

Vancouver, BC, June 10, 2009 – OneMove Technologies Inc. (“OneMove” or the “Company”)

VANCOUVER, BC: Genome British Columbia and the Centre for Drug Research and Development (CDRD) announced today a new development fund that offers BC's researchers another avenue to move promising research along the commercialization path. Genome BC has earmarked $1 million for the fund to be provided on a project by project basis, which is matched by CDRD. The intent is for Genome BC and CDRD to leverage this fund to attract further investment from other parties.

VANCOUVER, BC, CANADA – June 8, 2009 – Voice Mobility International, Inc. (TSE: VMY, OTCBB: VMII and FWB: VMY), a Vancouver based developer and provider of carrier and enterprise unified communication solutions, today announced it has closed a non-brokered private placement of 5,000,000 units at a purchase price of Cdn$0.10 per unit for aggregate gross proceeds to the Company of Cdn$500,000.

Vancouver, BC - At a time when the Canadian economy is under significant pressure, Genome BC is making investments in genomics research groups in British Columbia, which will help position the Province to capture specific and significant future scientific opportunities in the global knowledge-based economy.

Today Genome BC is announcing the second round of funding through the Science Opportunities Fund. Through this initiative, 10 BC-based research teams will be approved to launch genomics research projects valued at just over $2.7 million.

Vancouver, BC, May 26, 2009 - IP Applications Corp. (TSX-Venture: IPX) ("IP Applications" or the "Company") today announces that it has signed a term sheet with Pender Growth Fund (VCC) Inc. ("Pender"), a major shareholder of the Company, pursuant to which the Company has agreed to negotiate with Pender the terms of a non-brokered private placement to raise $1,000,000 through the issuance to Pender of 10% convertible preferred shares (the "Shares") of the Company at a price of $0.12 per Share (the "Offering").

VANCOUVER, B.C. - May 19, 2009 – Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) medical device company developing photodisinfection based products today announced a share exchange transaction with Grafton Resource Investments Ltd. ("Grafton"), a Closed-End Fund managed by Newland Fund Management LLP of London, England.

--Proceeds Will Advance Key New Products Including Completing CE Mark Application for the Reducer™ Stent for Refractory Angina--

CON-SPACE Communications Ltd. (the “Company” or “CON-SPACE”) (TSX-V: CCB), (http://www.con-space.com), today announced that, further to its news release of April 3, 2009, it has closed its private placement of 22,000,000 common shares at $0.05 each, for gross proceeds of $1,100,000 (the “Offering”), to Turret Oy Ab (“Turret”), its largest shareholder and secured lender.

TELUS investment part of Teradici’s new US $17 million funding round

Burnaby, British Columbia April 7, 2009 – Teradici Corporation, the industry leader in delivering a true PC experience over standard IP networks, today announced completion of a US $17 million series C funding round for its PC-over-IP network-delivered computing technology. With network-delivered computing, users can work at inexpensive computer stations at any site, with all operating systems, applications, and data residing in central datacenters.